Franklin Resources’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.6M | Buy |
1,042,558
+19,768
| +2% | +$201K | ﹤0.01% | 1107 |
|
2025
Q1 | $5.71M | Buy |
1,022,790
+72,268
| +8% | +$403K | ﹤0.01% | 1297 |
|
2024
Q4 | $7.67M | Buy |
950,522
+63
| +0% | +$508 | ﹤0.01% | 1202 |
|
2024
Q3 | $9.07M | Buy |
950,459
+196,804
| +26% | +$1.88M | ﹤0.01% | 1158 |
|
2024
Q2 | $5.33M | Buy |
753,655
+3,139
| +0.4% | +$22.2K | ﹤0.01% | 1287 |
|
2024
Q1 | $10.3M | Hold |
750,516
| – | – | ﹤0.01% | 1067 |
|
2023
Q4 | $6.9M | Buy |
750,516
+105
| +0% | +$966 | ﹤0.01% | 1033 |
|
2023
Q3 | $4.54M | Buy |
750,411
+732,487
| +4,087% | +$4.43M | ﹤0.01% | 1113 |
|
2023
Q2 | $139K | Buy |
+17,924
| New | +$139K | ﹤0.01% | 2461 |
|
2020
Q3 | – | Sell |
-125,000
| Closed | -$3.2M | – | 1884 |
|
2020
Q2 | $3.2M | Buy |
+125,000
| New | +$3.2M | ﹤0.01% | 1059 |
|